These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 30324628)

  • 1. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
    Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
    J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
    Huang JW; Luo XY; Li ZH; Lang BP
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
    Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
    Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.
    Zhang LL; Zhang LF; Guo XH; Zhang DZ; Yang F; Fan YY
    DNA Cell Biol; 2018 Jan; 37(1):46-52. PubMed ID: 29215918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression.
    Pan QH; Fan YH; Wang YZ; Li DM; Hu CE; Li RX
    J Biol Regul Homeost Agents; 2020; 34(3):795-805. PubMed ID: 32691576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer.
    Esfandi F; Taheri M; Kahaei MS; Omrani MD; Kholghi Oskooei V; Ghafouri-Fard S
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e191-e196. PubMed ID: 31309731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
    Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
    J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression.
    Shen Q; Jiang Y
    Biomed Pharmacother; 2018 Sep; 105():176-181. PubMed ID: 29857296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer.
    Ma HW; Xi DY; Ma JZ; Guo M; Ma L; Ma DH; Li PW; Guo CA
    Dis Markers; 2020; 2020():8140989. PubMed ID: 32051698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.
    Li Y; Zhu G; Ma Y; Qu H
    J Cell Biochem; 2019 Dec; 120(12):19457-19468. PubMed ID: 31478245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA
    Wu D; Zhang T; Wang J; Zhou J; Pan H; Qu P
    Aging (Albany NY); 2019 Dec; 11(24):12624-12640. PubMed ID: 31848324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis.
    Ding Z; Lan H; Xu R; Zhou X; Pan Y
    Pathol Res Pract; 2018 Dec; 214(12):1993-1999. PubMed ID: 30279010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.